Literature DB >> 30325863

Evaluation of a Mixed Meal Test for Diagnosis and Characterization of PancrEaTogEniC DiabeTes Secondary to Pancreatic Cancer and Chronic Pancreatitis: Rationale and Methodology for the DETECT Study From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Phil A Hart, Dana K Andersen1, Kieren J Mather2, Alicia C Castonguay, Mandeep Bajaj3, Melena D Bellin4, David Bradley5, Noemy Contreras6, Aida Habtezion7, Murray Korc8, Yogish Kudva9, Maxim S Petrov10, David C Whitcomb11, Dhiraj Yadav12, Ying Yuan6, Jo Ann S Rinaudo13, Sudhir Srivastava13, Jose Serrano1, Mark O Goodarzi14.   

Abstract

Pancreatogenic diabetes mellitus is most commonly the result of chronic pancreatitis but can also occur secondary to pancreatic cancer. The early identification of pancreatogenic diabetes and distinction from the more prevalent type 2 diabetes are clinically significant; however, currently, there is no validated method to differentiate these diabetes subtypes. We describe a study, "Evaluation of a Mixed Meal Test for Diagnosis and Characterization of PancrEaTogEniC DiabeTes Secondary to Pancreatic Cancer and Chronic Pancreatitis: the DETECT study," that seeks to address this knowledge gap. The DETECT study is a multicenter study that will examine differences in hormone and glucose excursions after a mixed meal test. The study will also create a biorepository that will be used to evaluate novel diagnostic biomarkers for differentiating these diabetes subtypes.

Entities:  

Mesh:

Year:  2018        PMID: 30325863      PMCID: PMC6195331          DOI: 10.1097/MPA.0000000000001168

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  49 in total

Review 1.  Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.

Authors:  Phil A Hart; Melena D Bellin; Dana K Andersen; David Bradley; Zobeida Cruz-Monserrate; Christopher E Forsmark; Mark O Goodarzi; Aida Habtezion; Murray Korc; Yogish C Kudva; Stephen J Pandol; Dhiraj Yadav; Suresh T Chari
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-10-12

2.  Defects in α-Cell Function in Patients With Diabetes Due to Chronic Pancreatitis Compared With Patients With Type 2 Diabetes and Healthy Individuals.

Authors:  Lena Mumme; Thomas G K Breuer; Stephan Rohrer; Nina Schenker; Björn A Menge; Jens J Holst; Michael A Nauck; Juris J Meier
Journal:  Diabetes Care       Date:  2017-07-27       Impact factor: 19.112

3.  Increased postprandial response of glucagon-like peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency.

Authors:  Mads Hornum; Jan F Pedersen; Steen Larsen; Ole Olsen; Jens J Holst; Filip K Knop
Journal:  Pancreatology       Date:  2010-05-12       Impact factor: 3.996

4.  Pancreatic Cancer-Derived Exosomes Cause Paraneoplastic β-cell Dysfunction.

Authors:  Naureen Javeed; Gunisha Sagar; Shamit K Dutta; Thomas C Smyrk; Julie S Lau; Santanu Bhattacharya; Mark Truty; Gloria M Petersen; Randal J Kaufman; Suresh T Chari; Debabrata Mukhopadhyay
Journal:  Clin Cancer Res       Date:  2014-10-29       Impact factor: 12.531

5.  Pancreatic polypeptide administration enhances insulin sensitivity and reduces the insulin requirement of patients on insulin pump therapy.

Authors:  Atoosa Rabiee; Panagis Galiatsatos; Rocio Salas-Carrillo; Michael J Thompson; Dana K Andersen; Dariush Elahi
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

6.  Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.

Authors:  Jan Škrha; Petr Bušek; Jana Uhrová; Petr Hrabal; Klára Kmochová; Martin Laclav; Bohuš Bunganič; Přemysl Frič
Journal:  Pancreatology       Date:  2016-12-15       Impact factor: 3.996

7.  Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis.

Authors:  F C Brunicardi; R L Chaiken; A S Ryan; N E Seymour; J A Hoffmann; H E Lebovitz; R E Chance; R L Gingerich; D K Andersen; D Elahi
Journal:  J Clin Endocrinol Metab       Date:  1996-10       Impact factor: 5.958

8.  Insulin resistance is a prominent feature of patients with pancreatogenic diabetes.

Authors:  H Yki-Järvinen; T Kiviluoto; M R Taskinen
Journal:  Metabolism       Date:  1986-08       Impact factor: 8.694

Review 9.  Diabetes mellitus secondary to pancreatic diseases (Type 3c)--are we neglecting an important disease?

Authors:  Nils Ewald; Reinhard G Bretzel
Journal:  Eur J Intern Med       Date:  2013-02-01       Impact factor: 4.487

10.  Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer.

Authors:  Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Lawrence J Timmons; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen
Journal:  Gastroenterology       Date:  2007-10-26       Impact factor: 22.682

View more
  14 in total

1.  Pancreatogenic diabetes, acute pancreatitis management, and pancreatic tuberculosis: Appraising the present and setting goals for the future.

Authors:  Jorge D Machicado; Georgios I Papachristou
Journal:  United European Gastroenterol J       Date:  2020-05       Impact factor: 4.623

Review 2.  Early detection of pancreatic cancer.

Authors:  Stephen P Pereira; Lucy Oldfield; Alexander Ney; Phil A Hart; Margaret G Keane; Stephen J Pandol; Debiao Li; William Greenhalf; Christie Y Jeon; Eugene J Koay; Christopher V Almario; Christopher Halloran; Anne Marie Lennon; Eithne Costello
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-03-02

3.  Is Screening for Pancreatic Cancer in High-Risk Individuals One Step Closer or a Fool's Errand?

Authors:  Phil A Hart; Suresh T Chari
Journal:  Clin Gastroenterol Hepatol       Date:  2018-09-27       Impact factor: 11.382

4.  PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies: Rationale and Study Design for PROCEED From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Authors:  Dhiraj Yadav; Walter G Park; Evan L Fogel; Liang Li; Suresh T Chari; Ziding Feng; William E Fisher; Christopher E Forsmark; Christie Y Jeon; Aida Habtezion; Phil A Hart; Steven J Hughes; Mohamed O Othman; Jo Ann S Rinaudo; Stephen J Pandol; Temel Tirkes; Jose Serrano; Sudhir Srivastava; Stephen K Van Den Eeden; David C Whitcomb; Mark Topazian; Darwin L Conwell
Journal:  Pancreas       Date:  2018 Nov/Dec       Impact factor: 3.327

5.  Predictors of Glycemic Outcomes at 1 Year Following Pediatric Total Pancreatectomy With Islet Autotransplantation.

Authors:  Sarah E Swauger; Lindsey N Hornung; Deborah A Elder; Appakalai N Balamurugan; David S Vitale; Tom K Lin; Jaimie D Nathan; Maisam Abu-El-Haija
Journal:  Diabetes Care       Date:  2022-02-01       Impact factor: 19.112

Review 6.  The spectrum of diabetes in acute and chronic pancreatitis.

Authors:  Søren S Olesen; Frederico G S Toledo; Phil A Hart
Journal:  Curr Opin Gastroenterol       Date:  2022-07-18       Impact factor: 2.741

7.  Rationale and Design for the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: A Prospective Cohort Study From the Type 1 Diabetes in Acute Pancreatitis Consortium.

Authors:  Phil A Hart; Georgios I Papachristou; Walter G Park; Anne-Marie Dyer; Vernon M Chinchilli; Elham Afghani; Venkata S Akshintala; Dana K Andersen; James L Buxbaum; Darwin L Conwell; Kathleen M Dungan; Jeffrey J Easler; Evan L Fogel; Carla J Greenbaum; Rita R Kalyani; Murray Korc; Richard Kozarek; Maren R Laughlin; Peter J Lee; Jennifer L Maranki; Stephen J Pandol; Anna Evans Phillips; Jose Serrano; Vikesh K Singh; Cate Speake; Temel Tirkes; Frederico G S Toledo; Guru Trikudanathan; Santhi Swaroop Vege; Ming Wang; Cemal Yazici; Atif Zaheer; Christopher E Forsmark; Melena D Bellin; Dhiraj Yadav
Journal:  Pancreas       Date:  2022-07-01       Impact factor: 3.243

Review 8.  Chronic Pancreatitis: Managing a Difficult Disease.

Authors:  Phil A Hart; Darwin L Conwell
Journal:  Am J Gastroenterol       Date:  2020-01       Impact factor: 12.045

Review 9.  Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review.

Authors:  Barbara Kenner; Suresh T Chari; David Kelsen; David S Klimstra; Stephen J Pandol; Michael Rosenthal; Anil K Rustgi; James A Taylor; Adam Yala; Noura Abul-Husn; Dana K Andersen; David Bernstein; Søren Brunak; Marcia Irene Canto; Yonina C Eldar; Elliot K Fishman; Julie Fleshman; Vay Liang W Go; Jane M Holt; Bruce Field; Ann Goldberg; William Hoos; Christine Iacobuzio-Donahue; Debiao Li; Graham Lidgard; Anirban Maitra; Lynn M Matrisian; Sung Poblete; Laura Rothschild; Chris Sander; Lawrence H Schwartz; Uri Shalit; Sudhir Srivastava; Brian Wolpin
Journal:  Pancreas       Date:  2021-03-01       Impact factor: 3.243

Review 10.  Distinguishing diabetes secondary to pancreatic diseases from type 2 diabetes mellitus.

Authors:  Phil A Hart; Dana K Andersen; Maxim S Petrov; Mark O Goodarzi
Journal:  Curr Opin Gastroenterol       Date:  2021-09-01       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.